Home Halogens N,N′-Diisoprophyl phosphordiamide fluoride

N,N′-Diisoprophyl phosphordiamide fluoride

CAS No.:
371-86-8
Catalog Number:
AG00CZ9C
Molecular Formula:
C6H16FN2OP
Molecular Weight:
182.1762
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG00CZ9C
Chemical Name:
N,N′-Diisoprophyl phosphordiamide fluoride
CAS Number:
371-86-8
Molecular Formula:
C6H16FN2OP
Molecular Weight:
182.1762
MDL Number:
MFCD00801119
IUPAC Name:
N-[fluoro-(propan-2-ylamino)phosphoryl]propan-2-amine
InChI:
InChI=1S/C6H16FN2OP/c1-5(2)8-11(7,10)9-6(3)4/h5-6H,1-4H3,(H2,8,9,10)
InChI Key:
UOSHUBFBCPGQAY-UHFFFAOYSA-N
SMILES:
CC(NP(=O)(NC(C)C)F)C
EC Number:
206-742-3
UNII:
24MJP5H3YN
NSC Number:
8924
Properties
Complexity:
147  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
182.098g/mol
Formal Charge:
0
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
182.179g/mol
Monoisotopic Mass:
182.098g/mol
Rotatable Bond Count:
4  
Topological Polar Surface Area:
41.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1  
Literature
Title Journal
Phenyl valerate esterase activity of human butyrylcholinesterase. Archives of toxicology 20171001
High concentration of trichlorfon (1mM) disrupts axonal cytoskeleton and decreases the expression of plasticity-related proteins in SH-SY5Y cells. Toxicology in vitro : an international journal published in association with BIBRA 20170301
Butyrylcholinesterase identification in a phenylvalerate esterase-enriched fraction sensitive to low mipafox concentrations in chicken brain. Archives of toxicology 20170201
Effects of mipafox, paraoxon, chlorpyrifos and its metabolite chlorpyrifos-oxon on the expression of biomarker genes of differentiation in D3 mouse embryonic stem cells. Chemico-biological interactions 20161125
Resolving pathways of interaction of mipafox and a sarin analog with human acetylcholinesterase by kinetics, mass spectrometry and molecular modeling approaches. Archives of toxicology 20160301
Further studies toward a mouse model for biochemical assessment of neuropathic potential of organophosphorus compounds. Journal of applied toxicology : JAT 20141201
Genomic and phenotypic alterations of the neuronal-like cells derived from human embryonal carcinoma stem cells (NT2) caused by exposure to organophosphorus compounds paraoxon and mipafox. International journal of molecular sciences 20140101
Kinetics of the inhibitory interaction of organophosphorus neuropathy inducers and non-inducers in soluble esterases in the avian nervous system. Toxicology and applied pharmacology 20111101
Motor neuron disease due to neuropathy target esterase mutation: enzyme analysis of fibroblasts from human subjects yields insights into pathogenesis. Toxicology letters 20101110
Constructs of human neuropathy target esterase catalytic domain containing mutations related to motor neuron disease have altered enzymatic properties. Toxicology letters 20100701
Effect of inhibition of neuropathy target esterase in mouse nervous tissues in vitro on phosphatidylcholine and lysophosphatidylcholine homeostasis. International journal of toxicology 20090101
Molecular cloning and expression of the C-terminal domain of mouse NTE-related esterase. Molecular and cellular biochemistry 20071201
Molecular cloning and expression of chicken neuropathy target esterase activity domain. Toxicology letters 20071101
Biosensor assay of neuropathy target esterase in whole blood as a new approach to OPIDN risk assessment: review of progress. Human & experimental toxicology 20070401
The search of the target of promotion: Phenylbenzoate esterase activities in hen peripheral nerve. Toxicology and applied pharmacology 20070301
Mechanism of aging of mipafox-inhibited butyrylcholinesterase. Chemical research in toxicology 20070301
Over-expression of neuropathy target esterase activity in bovine chromaffin cell cultures by adenovirus-mediated gene transfer. Toxicology letters 20070205
Recovery of neuropathy target esterase activity after inhibition with mipafox and O-hexyl O-2,5-dichlorophenyl phosphoramidate in bovine chromaffin cell cultures. Chemico-biological interactions 20070130
Comparison of chromaffin cells from several animal sources for their use as an in vitro model to study the mechanism of organophosphorous toxicity. Toxicology letters 20060910
Degradation of organophosphorus neurotoxicity in SY5Y neuroblastoma cells by organophosphorus hydrolase (OPH). Journal of toxicology and environmental health. Part A 20060801
Aging of mipafox-inhibited human acetylcholinesterase proceeds by displacement of both isopropylamine groups to yield a phosphate adduct. Chemical research in toxicology 20060201
Reduction of neuropathy target esterase does not affect neuronal differentiation, but moderate expression induces neuronal differentiation in human neuroblastoma (SK-N-SH) cell line. Brain research. Molecular brain research 20051118
Effects of organophosphorus compounds on ATP production and mitochondrial integrity in cultured cells. Neurotoxicity research 20050101
Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of tiapride. Journal of applied toxicology : JAT 20050101
Neurofilament 200 as an indicator of differences between mipafox and paraoxon sensitivity in Sy5Y neuroblastoma cells. Journal of toxicology and environmental health. Part A 20040709
Bovine chromaffin cell cultures as model to study organophosporus neurotoxicity. Toxicology letters 20040615
The inhibition of the high sensitive peripheral nerve soluble esterases by mipafox. A new mathematical processing for the kinetics of inhibition of esterases by organophosphorus compounds. Toxicology letters 20040615
Lysophospholipase inhibition by organophosphorus toxicants. Toxicology and applied pharmacology 20040501
The mipafox-inhibited catalytic domain of human neuropathy target esterase ages by reversible proton loss. Biochemistry 20040330
In vitro protection of plasma cholinesterases by metoclopramide from inhibition by mipafox. Journal of applied toxicology : JAT 20040101
Relative inhibitory potencies of chlorpyrifos oxon, chlorpyrifos methyl oxon, and mipafox for acetylcholinesterase versus neuropathy target esterase. Journal of toxicology and environmental health. Part A 20030627
Neurotoxicity of polycyclic aromatic hydrocarbons and simple chemical mixtures. Journal of toxicology and environmental health. Part A 20030523
Properties of phenyl valerate esterase activities from chicken serum are comparable with soluble esterases of peripheral nerves in relation with organophosphorus compounds inhibition. Toxicology letters 20030430
Biosensor detection of neuropathy target esterase in whole blood as a biomarker of exposure to neuropathic organophosphorus compounds. Journal of toxicology and environmental health. Part A 20030411
Neurotoxicity induced in differentiated SK-N-SH-SY5Y human neuroblastoma cells by organophosphorus compounds. Toxicology and applied pharmacology 20030115
In vitro protection of red blood cell acetylcholinesterase by metoclopramide from inhibition by organophosphates (paraoxon and mipafox). Journal of applied toxicology : JAT 20030101
Inhibition of carboxylesterases in SH-SY5Y human and NB41A3 mouse neuroblastoma cells by organophosphorus esters. Journal of toxicology and environmental health. Part A 19980313
Acetylcholinesterase and neuropathy target esterase inhibitions in neuroblastoma cells to distinguish organophosphorus compounds causing acute and delayed neurotoxicity. Fundamental and applied toxicology : official journal of the Society of Toxicology 19970701
Potentiation of organophosphorus-induced delayed neurotoxicity following phenyl saligenin phosphate exposures in 2-, 5-, and 8-week-old chickens. Fundamental and applied toxicology : official journal of the Society of Toxicology 19970501
Subacute neurotoxicity induced in mice by potent organophosphorus neuropathy target esterase inhibitors. Toxicology and applied pharmacology 19960701
Comparison of the relative inhibition of acetylcholinesterase and neuropathy target esterase in rats and hens given cholinesterase inhibitors. Fundamental and applied toxicology : official journal of the Society of Toxicology 19950101
Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy. Toxicology and applied pharmacology 19931001
Biochemical properties and possible toxicological significance of various forms of NTE. Chemico-biological interactions 19930601
Delayed neurotoxic effect of sarin in mice after repeated inhalation exposure. Journal of applied toxicology : JAT 19930101
Comparative evolution of mipafox-induced delayed neuropathy in rats and hens. Neurotoxicology 19920101
Comparative dose-response studies of organophosphorus ester-induced delayed neuropathy in rats and hens administered mipafox. Neurotoxicology 19920101
Age sensitivity to organophosphate-induced delayed polyneuropathy. Biochemical and toxicological studies in developing chicks. Biochemical pharmacology 19910515
The correlation between neurotoxic esterase inhibition and mipafox-induced neuropathic damage in rats. Neurotoxicology 19860101
Phenylmethylsulfonyl fluoride protects rats from Mipafox-induced delayed neuropathy. Toxicology and applied pharmacology 19851101
Striatal neurochemical changes and motor dysfunction in mipafox-treated animals. Methods and findings in experimental and clinical pharmacology 19850201
Properties